kneat.com, inc. (TSE:KSI – Free Report) – Stock analysts at Stifel Canada upped their FY2024 earnings estimates for shares of kneat.com in a research report issued to clients and investors on Tuesday, November 12th. Stifel Canada analyst J. Keywood now forecasts that the company will earn ($0.13) per share for the year, up from their previous estimate of ($0.15). The consensus estimate for kneat.com’s current full-year earnings is ($0.12) per share. Stifel Canada also issued estimates for kneat.com’s Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.11) EPS.
Other analysts also recently issued reports about the company. Ventum Cap Mkts raised kneat.com to a “strong-buy” rating in a research report on Wednesday, August 7th. Cibc World Mkts upgraded shares of kneat.com to a “strong-buy” rating in a report on Tuesday, October 29th. Finally, CIBC set a C$6.00 target price on shares of kneat.com and gave the company an “outperform” rating in a report on Tuesday, October 29th.
kneat.com Trading Down 0.8 %
Shares of KSI opened at C$5.00 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.50 and a debt-to-equity ratio of 95.14. The firm has a 50-day moving average price of C$4.78 and a 200 day moving average price of C$4.54. kneat.com has a 12-month low of C$2.80 and a 12-month high of C$5.17. The firm has a market capitalization of C$430 million, a P/E ratio of -31.25, a P/E/G ratio of 597.67 and a beta of 1.08.
About kneat.com
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.
Further Reading
- Five stocks we like better than kneat.com
- 3 Tickers Leading a Meme Stock Revival
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Time to Load Up on Home Builders?
Receive News & Ratings for kneat.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for kneat.com and related companies with MarketBeat.com's FREE daily email newsletter.